Several studies have shown that there is a high level of activated transcription factor-kappa B in the intestinal mucosa of IBD patients, and nuclear transcription factor kappa B (NF-κB) is considered to be one of the most critical signaling pathways in IBD. Here, NFKB1 is linked to inflammatory bowel disease.